Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United S...
Q2 2026
Aug 5, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 5, 2026
Q4 2025
Q3 2025
Nov 4, 2025